Correction: Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain
Sofia Zelleroth, Ibrahim Kaya, Frida Stam, Johan Gising, Mats Larhed, Reza Shariatgorji, Anna Nilsson, Alfhild Grönbladh, Per E. Andrén, Mathias Hallberg Neuropsychopharmacology
· Springer Nature
· 2026-10-19
· DOI: 10.1038/s41386-026-02578-w
Abstract
Neuropsychopharmacology, Published online: 19 October 2026; doi:10.1038/s41386-026-02578-w Correction: Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain
Sofia Zelleroth, Ibrahim Kaya, Frida Stam, Johan Gising, Mats Larhed, Reza Shariatgorji et al. Correction: Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain. // Neuropsychopharmacology. – 2026. – DOI: 10.1038/s41386-026-02578-w. – URL: https://www.nature.com/articles/s41386-026-02578-w
Sofia Zelleroth, Ibrahim Kaya, Frida Stam, Johan Gising, Mats Larhed, Reza Shariatgorji, Anna Nilsson, Alfhild Grönbladh, Per E. Andrén, & Mathias Hallberg (2026). Correction: Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain. Neuropsychopharmacology. https://doi.org/10.1038/s41386-026-02578-w
Sofia Zelleroth, et al. “Correction: Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain.” Neuropsychopharmacology, 2026. doi:10.1038/s41386-026-02578-w.
@article{Zelleroth2026,
title = {Correction: Anabolic androgenic steroids induce distinct monoaminergic and lipidomic alterations in the male rat brain},
author = {Zelleroth, Sofia and Kaya, Ibrahim and Stam, Frida and Gising, Johan and Larhed, Mats and Shariatgorji, Reza and Nilsson, Anna and Grönbladh, Alfhild and Andrén, Per E. and Hallberg, Mathias},
journal = {Neuropsychopharmacology},
year = {2026},
doi = {10.1038/s41386-026-02578-w},
url = {https://www.nature.com/articles/s41386-026-02578-w}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...